On-Treatment Changes in FIB-4 and 1-Year FIB-4 Values Help Identify Patients with Chronic Hepatitis B Receiving Entecavir Therapy Who Have the Lowest Risk of Hepatocellular Carcinoma

Wang, HW; Lai, HC; Hu, TH; Su, WP; Lu, SN; Lin, CH; Hung, CH; Chuang, PH; Wang, JH; Lee, MH; Chen, CH; Peng, CY

Peng, CY (corresponding author), China Med Univ Hosp, Dept Internal Med, Ctr Digest Med, Taichung 404, Taiwan.; Chen, CH (corresponding author), Kaohsiung Chang Gung Mem Hosp, Coll Med, Dept Internal Med, Div Hepatogastroenterol, Kaohsiung 833, Taiwan.; Chen, CH (corresponding author), Chang Gung Univ, Kaohsiung 833, Taiwan.; Peng, CY (corresponding author), China Med Univ, Sch Med, Taichung 404, Taiwan.

CANCERS, 2020; 12 (5):

Abstract

Noninvasive fibrosis indices can help stratify the risk of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB) receiving nucleos......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索